Please login to the form below

Not currently logged in
Email:
Password:

Steglatro

This page shows the latest Steglatro news and features for those working in and with pharma, biotech and healthcare.

NICE recommends MSD’s diabetes drug Steglatro

NICE recommends MSD’s diabetes drug Steglatro

NICE has cleared MSD’s type 2 diabetes treatment Steglatro for routine NHS use in combination with metformin, or as a monotherapy for those who are intolerant to the anti-diabetic ... MSD is hoping Steglatro can take market share from other more

Latest news

  • The year of the blockbuster The year of the blockbuster

    Steglatro (ertugliflozin) from Pfizer and Merck:Sodium glucose co-transporter-2 (SGLT-2) inhibitors are the newest oral treatment options for diabetes, but SGLT-2 inhibitor Steglatro will be a late ... Steglatro has now been launched in the US and an EMA

  • FDA’s year-end approvals take annual tally to 46 FDA’s year-end approvals take annual tally to 46

    Merck and Pfizer picked up an FDA approval for SGLT2 inhibitor Steglatro (ertugliflozin) and combinations Steglujan (ertugliflozin and sitagliptin) and Segluromet (ertugliflozin and metformin) for use in adults with type 2 ... Steglatro and Steglujan are

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • NICE – but not enough NICE – but not enough

    Steglatro launched as a new SGLT2 in early 2019 and was quickly bolstered by two NICE TAs. ... Armed with positive NICE guidance, MSD did a great job of getting Steglatro on formulary.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Guide
How to embrace behavioural science principles in healthcare MR...
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...